Mechanisms involved in the antinociception caused by melatonin in mice

Journal of Pineal Research

Volumn 41, Issue 4, 2006, Pages 382-389

  Mantovani, Michela ^a   Kaster, Manuella P ^a   Pertile, Roberto ^a   Calixto, João B ^a   Rodrigues, Ana Lúcia S ^a   Santos, Adair R S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Capsaicin; Glutamate; Melatonin; Monoamine; Nociception

Indexed keywords

ARGININE; CAPSAICIN; DEXTRO ARGININE; GLUTAMIC ACID; KETANSERIN; LUZINDOLE; MELATONIN; NALOXONE; PRAZOSIN; SULPIRIDE; YOHIMBINE;

ADRENALECTOMY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN;

ADRENALECTOMY; ANALGESICS; ANIMALS; CAPSAICIN; MALE; MELATONIN; MICE; PAIN;

EID: 33749338956     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2006.00380.x     Document Type: Article

References (47)

1. BOUTIN JA, AUDINOT V, FERRY G et al. Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci 2005; 26:412-419.
2. GOLDMAN BD. The circadian timing system and reproduction in mammals. Steroids 1999; 64:679-685.
3. ARENDT J, SKENE DJ. Melatonin as a chronobiotic. Sleep Med Rev 2005; 9:25-39.
4. GOLOMBEK DA, PEVET P, CARDINALI DP. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci Biobehav Rev 1996; 20:403-412.
5. MANTOVANI M, PÉRTILE R, CALIXTO JB et al. Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway. Neurosci Lett 2003; 343:1-4.
6. TUREK FW, GILLETTE MU. Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists. Sleep Med 2004; 5:523-532.
7. TOMÁS-ZAPICO C, COTO-MONTES A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005; 39:99-104.
8. PAPP M, LITWA E, GRUCA P et al. Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. Behav Pharmacol 2006; 17:9-18.
9. DUBOCOVICH ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995; 16:50-56.
10. ALMAY BG, VON KNORRING L, WETTERBERG L. Melatonin in serum and urine in patients with idiopathic pain syndromes. Psychiatry Res 1987; 22:179-191.
11. WIKNER J, HIRSCH U, WETTERBERG L, ROJDMARK S. Fibromyalgia: a syndrome associated with decreased nocturnal melatonin secretion. Clin Endocrinol 1998; 49:179-183.
12. KORSZUN A, SACKETT-LUNDEEN L, PAPADOPOULOS E et al. Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 1999; 26:2675-2680.
13. CITERA G, ARIAS MA, MALDONADO-COCCO JA et al. The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol 2000; 19:9-13.
14. GOLOMBEK DA, ESCOLAR E, BURIN LJ et al. Time-dependent melatonin analgesia in mice: inhibition by opiate or benzodiazepine antagonism. Eur J Pharmacol 1991; 194:25-30.
15. YU CX, ZHU B, XU SF et al. The analgesic effects of peripheral and central administration of melatonin in rats. Eur J Pharmacol 2000; 403:49-53.
16. 2 melatonin receptor antagonist blocks melatonin-induced antinociception in rats. Neurosci Lett 2000; 282:161-164.
17. ONAL SA, INALKAC S, KUTLU S et al. Intrathecal melatonin increases the mechanical nociceptive threshold in the rat. Agri 2004; 16:35-40.
18. SHAVALI S, HO B, GOVITRAPONG P et al. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res Bull 2005; 64:471-479.
19. LI SR, WANG T, WANG R et al. Melatonin enhances antinociceptive effects of delta- but not mu-opioid agonist in mice. Brain Res 2005; 1043:132-138.
20. PANG CS, TSANG SF, YANG JC. Effects of melatonin, morphine and diazepam on formalin-induced nociception in mice. Life Sci 2001; 68:943-951.
21. ZIMMERMANN M. Ethical Guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16:109-110.
22. BEIRITH A, SANTOS ARS, CALIXTO JB. Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. Brain Res 2002; 924:219-228.
23. SANTOS ARS, MIGUEL OG, YUNES RA et al. Antinociceptive properties of the new alkaloid, cis-8, 10-di-N-propyllobelidiol hydrochloride dihydrate isolated from Siphocampylus verticillatus: evidence for the mechanism of action. J Pharmacol Exp Ther 1999; 289:417-426.
24. SANTOS ARS, TRENTIN AP, FERREIRA J et al. Mechanisms involved in the antinociception caused by compound MV8612 isolated from Mandevilla velutina in mice. Brain Res 2003; 961:269-276.
25. SANTOS ARS, GADOTTI VM, OLIVEIRA GL et al. Mechanisms involved in the antinociception caused by agmatine in mice. Neuropharmacology 2005; 48:1021-1034.
26. RODRIGUES ALS, ROCHA JBT, MELLO CF et al. Effect of perinatal lead exposure on rat behavior in open-field and two-way avoidance tasks. Pharmacol Toxicol 1996; 79:150-156.
27. WONG PT, ONG YP. Acute antidepressant-like and antianxiety-like effects of tryptophan in mice. Pharmacology 2001; 62:151-156.
28. CHIZH BA. Novel approaches to targeting glutamate receptors for the treatment of chronic pain: review article. Amino Acids 2002; 23:169-176.
29. MILLAN MJ. Descending control of pain. Prog Neurobiol 2002; 66:355-474.
30. BODNAR RJ, KLEIN GE. Endogenous opiates and behavior: 2004. Peptides 2005; 26:2629-2711.
31. ZUBIETA JK, SMITH YR, BUELLER JA et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001; 293:311-315.
32. 2 receptors in spinal cord in the control of nociceptive responsiveness. Neuropharmacology 1991; 30:727-731.
33. CRISP T, STAFINSKY JL, URAM M et al. Serotonin contributes to the spinal antinociceptive effects of morphine. Pharmacol Biochem Behav 1991; 39:591-595.
34. BARDIN L, LAVARENNE J, ESCHALIER A. Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain 2000; 86:11-18.
35. 3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur J Pharmacol 2001; 424:45-52.
36. 3H]serotonin release in the rat hippocampus: effects of circadian rhythm. J Neuroendocrinol 2002; 14:194-199.
37. CHUANG JI, CHEN SS, LIN MT. Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats. Pharmacology 1993; 47:91-97.
38. 2 receptor agonists and antagonists on opioid antinociception. Eur J Pharmacol 1989; 168:329-336.
39. FRUSSA-FILHO R, ROCHA JB, CONCEICAO IM et al. Effects of dopaminergic agents on visceral pain measured by the mouse writhing test. Arch Int Pharmacodyn Ther 1996; 331:74-93.
40. 2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 2003; 987:135-143.
41. 2 dopamine receptors in the rat striatum. Life Sci 1998; 63:2115-2120.
42. ESCAMES G, CASTROVIEJO DA, VIVES F. Melatonin-dopamine interaction in the striatal projection area of sensorimotor cortex in the rat. NeuroReport 1996; 7:597-600.
43. LEON J, MACIAS M, ESCAMES G et al. Structure-related inhibition of calmodulin-dependent neuronal nitric-oxide synthase activity by melatonin and synthetic kynurenines. Mol Pharmacol 2000; 58:967-975.
44. ULOGOL A, DOKMECI D, GURAY G et al. Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: possible involvements of the L-arginine-NO pathway and opioid system. Life Sci 2006; 78:1592-1597.
45. KURAISHI Y, HIROTA N, SATO Y et al. Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn. Brain Res 1985; 359:177-182.
46. KAMISAKI Y, HAMADA T, MAEDA K et al. Presynaptic alpha 2-adrenoceptors inhibit glutamate release from rat spinal cord synaptosomes. J Neurochem 1993; 60:522-526.
47. BLACKBURN-MUNRO G, BLACKBURN-MUNRO RE. Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol 2001; 13:1009-1023.